[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.1055/s-0042-1756295

Late Seroma in Breast Implants: A Coronavirus Disease 2019 Phenomenon?

Chan, Stephanie L.S (Department of Plastic, Reconstructive and Aesthetic Surgery, KK Women's and Children's Hospital)
Mok, James Wan Loong (Department of Plastic, Reconstructive and Aesthetic Surgery, KK Women's and Children's Hospital)

Publication Information

Archives of Plastic Surgery / v.49, no.5, 2022 , pp. 611-613 More about this Journal

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has been challenging in all aspects of the medical field with new clinical presentations constantly arising. Plastic surgeons are not immune to this and need to be aware of their implications. There has been a recent report of late periprosthetic seroma (breast implant) as a clinical manifestation of COVID-19 infection. To our knowledge, this phenomenon has not been further reported. We present a 53-year-old immunocompromised lady who developed late seroma after COVID-19 infection. She eventually required explantation of the implant and is awaiting autologous reconstruction. It is likely that we will increasingly continue to see this phenomenon of implant complications as a result of COVID-19 infection and should be watchful, especially regarding potential immunocompromised patients.

Keywords

late seroma; seroma; breast implant; coronavirus; coronavirus disease 2019;

Citations & Related Records

Reference

1	Kayser F, Fourneau H, Mazy OC, Mazy S. Breast implant seroma: a SARS-CoV-2 mRNA vaccine side effect. J Clin Ultrasound 2021;49(09):984-986 DOI
2	Restifo RJ. A case report of capsular contracture immediately following COVID-19 vaccination. Aesthet Surg J Open Forum 2021;3(03):ojab021 DOI
3	Munavalli GG, Guthridge R, Knutsen-Larson S, Brodsky A, Matthew E, Landau M. COVID-19/SARS-CoV-2 virus spike proteinrelated delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment. Arch Dermatol Res 2022;314(01):1-15 DOI
4	Nunez PM, Gonzalez MP, Cordero AJ. Late seroma of the breast in association with COVID-19 infection: two case reports. Eur J Plast Surg 2021;1-4:1-4
5	U.S. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee Meeting; FDA Briefing Document for Moderna COVID 19. Vaccine. Accessed March 22, 2021, at: https://www.fda.gov/media/144434/download
6	Weitgasser L, Mahrhofer M, Schoeller T. Potential immune response to breast implants after immunization with COVID-19 vaccines. Breast 2021;59:76-78 DOI
7	Mahrhofer M, Weitgasser L, Schoeller T. Observations of a potential immune response to breast implants after immunization with COVID-19 vaccines. Aesthet Surg J Open Forum 2021;3(04):ojab035 DOI